XM does not provide services to residents of the United States of America.

Solvay beats Q2 core profit view amid cost-cutting measures, ups guidance



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-Solvay beats Q2 core profit view amid cost-cutting measures, ups guidance</title></head><body>

Adds CEO and analyst quotes, details in paragraph 9

By Alban Kacher and Leo Marchandon

July 31 (Reuters) -Belgian chemicals group Solvay SOLB.BR reported a stronger-than-expected core profit for the second quarter on Wednesday, as higher volumes and further improvements in fixed costs offset pressure from negative net pricing.

Earnings before interest, taxes, depreciation, and amortization (EBITDA) came in at 272 million euros ($294.43 million), compared with the 261 million euros expected by analysts in a company-provided consensus.

"Our focus on deploying our cost-saving initiatives was key, and the 46 million euros of structural cost savings achieved so far are a testimony of the hard work of our teams," said group CEO Philippe Kehren in a press release.

Solvay has been cutting costs due to soft demand and a volatile macro and geopolitical environment. It aims to save 300 million euros by 2028.

Chemical companies have been under pressure for more than a year, forced to reduce inventories on lower demand from industrial clients as energy prices soared.

Earnings were robust with improvement to full-year free cash flow guidance despite higher investments in the second half of the year, said analyst Sebastian Bray from Berenberg.

"It is nice to see businesses outside soda ash outperforming expectations," Bray added.

Solvay tightened its forecast for 2024 underlying EBITDA to a 10-15% rangefrom earlier expectation of a 10-20% drop. It upgraded its free cash flow forecast to more than 300 million euros, from a previous goal of above 260 million euros.

The company reported net sales of 1,194 million euros for the second quarter, while analysts had expected 1,203 million euros.

Solvay's volumes improved in most of its markets, both in basic and performance chemicals. However, this positive trend was offset by the impact of lower net pricing, which dragged core profit from basic chemicals 25.6% lower.




Reporting by Alban Kacher and Leo Marchandon; Editing by Subhranshu Sahu and Eileen Soreng

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.